International advisory committee

  • Heike Allgayer, DKFZ, Heidelberg, Germany
  • Menashe Bar-Eli, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  • Joan Brugge, Harvard Medical School, Boston, MA, USA
  • Peter Carmeliet, Vesalius Research Center, Leuven, Belgium
  • Hans Clevers, Hubrecht Institute, Utrecht, Netherlands
  • Carlo M Croce, Ohio State University, Columbus, OH, USA
  • Janine Erler, University of Copenhagen, Copenhagen, Denmark
  • Hervé Fridman, University Paris Descartes, Paris, France
  • Peter Krammer, DKFZ, Heidelberg, Germany
  • Luyuan Li, Nankai University, Tianjin, China
  • Alberto Mantovani, Humanitas Clinical and Research Center, Milan, Italy
  • Suresh Mohla, National Cancer Institute, NIH, Rockville, MD, USA
  • Jacques Pouyssegur, Centre Antoine Lacassagne, Nice, France
  • Arne Östman, Karolinska Institutet, Stockholm, Sweden
  • Avraham Raz, Wayne State University, Detroit, MI, USA
  • Blanka Rihova, Academy of Sciences, Prague, Czech Republic
  • Fernando Vidal Vanaclocha, San Pablo University, Madrid, Spain
  • Robert Weinberg, Massachusetts Institute of Technology, Cambridge, MA, USA